Biofrontera, Inc. (BFRI)
1.53
-0.03
(-1.92%)
USD |
NASDAQ |
Sep 09, 16:00
1.54
+0.01
(+0.65%)
After-Hours: 16:28
Biofrontera Total Liabilities (Quarterly) : 18.11M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 18.11M |
| March 31, 2026 | 18.72M |
| December 31, 2025 | 18.08M |
| September 30, 2025 | 18.00M |
| June 30, 2025 | 24.81M |
| March 31, 2025 | 16.12M |
| December 31, 2024 | 17.67M |
| September 30, 2024 | 12.99M |
| June 30, 2024 | 10.66M |
| March 31, 2024 | 29.99M |
| December 31, 2023 | 23.14M |
| Date | Value |
|---|---|
| September 30, 2023 | 33.07M |
| June 30, 2023 | 29.73M |
| March 31, 2023 | 25.21M |
| December 31, 2022 | 27.01M |
| September 30, 2022 | 32.46M |
| June 30, 2022 | 36.39M |
| March 31, 2022 | 31.79M |
| December 31, 2021 | 41.88M |
| September 30, 2021 | 32.73M |
| June 30, 2021 | 19.06M |
| March 31, 2021 | 18.50M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 24.06M |
| Shareholders Equity (Quarterly) | 5.956M |
| Debt to Equity Ratio | 1.260 |
| Current Ratio | 1.180 |
| Net Debt Paydown Yield | -3.93% |